roastamount83
About
Subsequent main malignancy soon after rituximab-containing immunochemotherapy pertaining to soften huge B cell lymphoma.
Subsequent main malignancy soon after rituximab-containing immunochemotherapy pertaining to soften huge B cell lymphoma.